AgTalk Home
AgTalk Home
Search Forums | Classifieds (138) | Skins | Language
You are logged in as a guest. ( logon | register )

Ivermectin
View previous thread :: View next thread
   Forums List -> AgTalk CafeMessage format
 
OntarioCanuck
Posted 10/2/2021 21:23 (#9249639 - in reply to #9249468)
Subject: Another share


North of London

Here is something else to read up on about India cases

https://healthfeedback.org/claimreview/no-data-available-to-suggest-a-link-between-indias-reduction-of-covid-19-cases-and-the-use-of-ivermectin-jim-hoft-gateway-pundit/

According to official documents, ivermectin was included in India’s guideline as a possible treatment for mild COVID-19 as early as 28 April 2021. The daily number of COVID-19 cases started to decrease on 8 May 2021 after a sharp increase. However, the fact that event B occurs after event A isn’t enough to show that A caused B. Making this assumption without any further evidence is called the post hoc ergo propter hocfallacy. In this case, Gateway Pundit didn’t provide evidence to prove that the inclusion of ivermectin in the guideline caused the decline in new cases. Therefore, their claim is unsubstantiated.
...........
If the reduction in COVID-19 cases were due to ivermectin, then we wouldn’t expect to see any sign of improvement until after the release of the updated guidelines. However, the data show a reduction in the reproduction number, known as R, starting from 16 April 2021 (Figure 2). The 
reproduction number R represents how many people an infected person will go on to infect on average. The higher R is, the faster and more broadly the disease will spread. If R falls below 1, the number of new cases in the population will also fall.
The R number for India was estimated at 1.46 on 16 April 2021 and decreased to 0.97 as of 15 May 2021. Given that fewer new cases of infection were occurring, we would expect to observe a reduction in reported cases, as seen since 8 May 2021. Since R began decreasing before the new guidelines were issued, the reduction in cases cannot be due to ivermectin treatment. This observation contradicts the claim by Gateway Pundit
If ivermectin had an effect in curbing the spread of COVID-19, one might expect to only see limited contagion in countries that officially recommended this drug. Peru 
recommended ivermectin for mild COVID-19 as early as 8 May 2020. Official support for this drug also occurred in other countries in Latin America. However, these countries have experienced multiple waves of COVID-19 cases and deaths throughout 2020 and 2021 despite the ivermectin recommendation in place (Figure 3). Peru withdrew its recommendation in March 2021.
.............
As shown earlier, the epidemiological data doesn’t support the claim that ivermectin recommendation in India slowed the spread of the disease or reduced its death toll. In addition, clinical data don’t support the claim that ivermectin is effective for treating COVID-19. Many clinical studies and trials have been performed or are underway. However, few of them are designed in a way that would provide robust evidence. Health Feedback explained in 
several fact-checks that most of these studies are inconclusive because they were at high risk of bias.

Top of the page Bottom of the page


Jump to forum :
Search this forum
Printer friendly version
E-mail a link to this thread

(Delete cookies)